Belgian pharmacogenomic lab DNAVision this week said that it will now offer Affymetrix’s Genome-Wide Human SNP Array 6.0. DNAVision claims to be the first full-service PGx lab to provide the SNP Array 6.0 in Europe.
Quest Diagnostics is now offering a molecular diagnostic test that can detect chromosome abnormalities associated with 85 developmental disorders affecting children, the firm said last week.
The test, ClariSure is an array comparative genomic hybridization test that will be used to diagnose patients with mental retardation and Down syndrome among other disorders. Quest said it expects to provide physicians with test results within five days of receiving specimens at one of its facilities.
The test is based on technologies developed by Quest’s Nichols Institute and other licensed methodologies.
Iconix Biosciences last month launched DrugMatrix Online 1.0, which provides users with web-based access to a full-featured version of its DrugMatrix database.
According to Iconix, researchers can access DrugMatrix Online from any location using only a personal computer. DrugMatrix Online allows licensed users to securely upload Affymetrix gene expression data from the Rat 230 2.0, RAE230A, or RGU34A GeneChips and obtain a drug signature similarity scoring as well as extensive comparative data from a collection of reference information on rats treated with more than 500 reference drugs and toxicants.
Syngene, an imaging company, said this week that two of its G:BOX multi-application imaging systems have shown “excellent performance” with SuperArray Bioscience’s Oligo GEArrays.
According to Syngene, researchers at SuperArray Bioscience evaluated their Oligo GEArrays using the G:BOX Chemi HR16 and G:BOX Chemi XT16 imaging systems. They found using a G:BOX Chemi HR16, they could image eight arrays simultaneously and with the G:BOX Chemi XT16, 32 arrays at the same time.